Diazeniumdiolates: Pro- and antioxidant applications of the 'NONOates'

Free Radical Biology and Medicine

Volumn 28, Issue 10, 2000, Pages 1463-1469

  Fitzhugh, Anthony L ^a   Keefer, Larry K ^b  

^a SAIC FREDERICK INC   (United States)

^b Laboratory of Comparative Carcinogenesis   (United States)

Author keywords

Diazeniumdiolates; Free radicals; Nitric oxide; NONOates

Indexed keywords

DIAZENIUMDIOLIC ACID DERIVATIVE; NITRIC OXIDE; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; BRAIN VASOSPASM; CANCER THERAPY; CONFERENCE PAPER; DRUG STRUCTURE; HUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RADIOSENSITIZATION;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; LIPOPROTEINS, LDL; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; OXIDANTS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 0034656841     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00251-3     Document Type: Conference Paper

References (33)

1. Keefer L.K., Nims R.W., Davies K.M., Wink D.A. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors Convenient nitric oxide dosage forms . Methods Enzymol. 268:1996;281-293.
2. Keefer L.K. Nitric oxide-releasing compounds from basic research to promising drugs . CHEMTECH. 28:1998;30-35.
3. Hou Y.-C., Janczuk A., Wang P.G. Current trends in the development of nitric oxide donors. Curr. Pharm. Des. 5:1999;417-441.
4. Wink D.A., Osawa Y., Darbyshire J.F., Jones C.R., Eshenaur S.C., Nims R.W. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys. 300:1993;115-123.
5. Kowaluk E.A., Fung H.-L. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 255:1990;1256-1264.
6. McAninly, J.; Williams, D. L. H.; Askew, S. C.; Butler, A. R.; Russell, C. Metal ion catalysis in nitrosothiol (RSNO) decomposition. J. Chem. Soc. Chem. Commun.1758-1759; 1993.
7. Kanner J., Harel S., Granit R. Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289:1991;130-136.
8. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 9:1996;836-844.
9. Goss S.P.A., Hogg N., Kalyanaraman B. The effect of nitric oxide release rates on the oxidation of human low density lipoprotein. J. Biol. Chem. 272:1997;21647-21653.
10. Wink D.A., Hanbauer I., Krishna M.C., DeGraff W., Gamson J., Mitchell J.B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA. 90:1993;9813-9817.
11. Wink D.A., Cook J.A., Pacelli R., DeGraff W., Gamson J., Liebmann J., Krishna M.C., Mitchell J.B. The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity a direct correlation between nitric oxide formation and protection . Arch. Biochem. Biophys. 331:1996;241-248.
12. Wink D.A., Cook J.A., Krishna M.C., Hanbauer I., DeGraff W., Gamson J., Mitchell J.B. Nitric oxide protects against alkyl peroxide-mediated cytotoxicity further insights into the role nitric oxide plays in oxidative stress . Arch. Biochem. Biophys. 319:1995;402-407.
13. Pacelli R., Wink D.A., Cook J.A., Krishna M.C., DeGraff W., Friedman N., Tsokos M., Samuni A., Mitchell J.B. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J. Exp. Med. 182:1995;1469-1479.
14. Bonner F.T., Ravid B. Thermal decomposition of oxyhyponitrite (sodium trioxodinitrate(II)) in aqueous solution. Inorg. Chem. 14:1975;558-563.
15. Ma X.L., Gao F., Liu G.-L., Lopez B.L., Christopher T.A., Fukuto J.M., Wink D.A., Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc. Natl. Acad. Sci. USA. 96:1999;14617-14622.
16. Raspi G., Cinquantini A. Oxidative determination of α-hyponitrate with alkaline hexacyanoferrate(III). Anal. Chim. Acta. 72:1974;200-204.
17. Fukuto J.M., Hobbs A.J., Ignarro L.J. Conversion of nitroxyl (HNO) to nitric oxide (NO) in biological systems the role of physiological oxidants and relevance to the biological activity of HNO . Biochem. Biophys. Res. Commun. 196:1993;707-713.
18. Vidwans A.S., Kim S., Coffin D.O., Wink D.A., Hewett S.J. Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture. J. Neurochem. 72:1999;1843-1852.
19. Miles A.M., Bohle D.S., Glassbrenner P.A., Hansert B., Wink D.A., Grisham M.B. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem. 271:1996;40-47.
20. Okamoto T., Akaike T., Nagano T., Miyajima S., Suga M., Ando M., Ichimori K., Maeda H. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite a novel mechanism for procollagenase activation involving nitric oxide . Arch. Biochem. Biophys. 342:1997;261-274.
21. Pluta R.M., Oldfield E.H., Boock R.J. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J. Neurosurg. 87:1997;746-751.
22. Wolf E.W., Banerjee A., Soble-Smith J., Dohan F.C. Jr, White R.P., Robertson J.T. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J. Neurosurg. 89:1998;279-288.
23. Wink D.A., Vodovotz Y., Cook J.A., Krishna M.C., Kim S., Coffin D., DeGraff W., Deluca A.M., Liebmann J., Mitchell J.B. The role of nitric oxide chemistry in cancer treatment. Biochemistry (Transl. of Biokhimiya [Moscow]). 63:1998;802-809.
24. Liebmann, J.; DeLuca, A. M.; Coffin, D.; Wink, D. A.; Keefer, L. K.; Mitchell, J. B. In vivo radioprotection of normal tissue with tumor radiosensitization by nitric oxide. Proc. Am. Assoc. Cancer Res. 35:649 (abstract 3868); 1994.
25. Liebmann J., DeLuca A.M., Coffin D., Keefer L.K., Venzon D., Wink D.A., Mitchell J.B. In vivo radiation protection by nitric oxide modulation. Cancer Res. 54:1994;3365-3368.
26. Saavedra J.E., Shami P.J., Wang L.Y., Davies K.M., Booth M.N., Citro M.L., Keefer L.K. Esterase-sensitive nitric oxide donors of the diazeniumdiolate family in vitro antileukemic activity . J. Med. Chem. 43:2000;261-269.
27. Saavedra J.E., Billiar T.R., Williams D.L., Kim Y.-M., Watkins S.C., Keefer L.K. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α-induced apoptosis and toxicity in the liver. J. Med. Chem. 40:1997;1947-1954.
28. Saavedra J.E., Booth M.N., Hrabie J.A., Davies K.M., Keefer L.K. Piperazine as a linker for incorporating the nitric oxide-releasing diazeniumdiolate group into other biomedically relevant functional molecules. J. Org. Chem. 64:1999;5124-5131.
29. Maragos C.M., Morley D., Wink D.A., Dunams T.M., Saavedra J.E., Hoffman A., Bove A.A., Isaac L., Hrabie J.A., Keefer L.K. Complexes of ·NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem. 34:1991;3242-3247.
30. Hrabie J.A., Klose J.R., Wink D.A., Keefer L.K. New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 58:1993;1472-1476.
31. Saavedra J.E., Southan G.J., Davies K.M., Lundell A., Markou C., Hanson S.R., Adrie C., Hurford W.E., Zapol W.M., Keefer L.K. Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J. Med. Chem. 39:1996;4361-4365.
32. Gow A.J., Thom S.R., Brass C., Ischiropoulos H. Electrochemical detection of nitric oxide in biological systems. Microchem. J. 56:1997;146-154.
33. Morley D., Maragos C.M., Zhang X.-Y., Boignon M., Wink D.A., Keefer L.K. Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. J. Cardiovasc. Pharmacol. 21:1993;670-676.